Compare · MTD vs TMO
MTD vs TMO
Side-by-side comparison of Mettler-Toledo International Inc. (MTD) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- MTD operates in Health Care, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $255.19B, about 7.5x MTD ($33.93B).
- Over the past year, MTD is up 22.1% and TMO is up 20.3% - MTD leads by 1.8 points.
- MTD has been more active in the news (26 items in the past 4 weeks vs 9 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Mettler-Toledo International Inc.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $33.93B
- $255.19B
- 1M return
- +1.76%
- -0.77%
- 1Y return
- +22.08%
- +20.26%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 1997
- News (4w)
- 26
- 9
- Recent ratings
- 25
- 25
Mettler-Toledo International Inc.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform. The company's industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of networked scales and software, and stand-alone scales for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community. It markets its products through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest MTD
- President and CEO Kaltenbach Patrick was granted 534 shares, increasing direct ownership by 11% to 5,510 units (SEC Form 4)
- Head of Process Analytics Keller Gerry was granted 62 shares, increasing direct ownership by 20% to 379 units (SEC Form 4)
- Chief Financial Officer Vadala Shawn was granted 176 shares, increasing direct ownership by 3% to 5,934 units (SEC Form 4)
- Head of PI, Retail, and GSC Wittorf Oliver was granted 51 shares, increasing direct ownership by 9% to 600 units (SEC Form 4)
- Head of Asia & Pacific Wong Ann Ping Richard was granted 64 shares, increasing direct ownership by 9% to 767 units (SEC Form 4)
- Director Salice Thomas P was granted 77 shares, increasing direct ownership by 26% to 369 units (SEC Form 4)
- Director Zhang Ingrid was granted 54 shares, increasing direct ownership by 26% to 261 units (SEC Form 4)
- Director Wienand Wolfgang was granted 54 shares, increasing direct ownership by 30% to 237 units (SEC Form 4)
- Director Tokich Michael J was granted 54 shares, increasing direct ownership by 108% to 104 units (SEC Form 4)
- Director Shuman-Fabbri Natalia was granted 54 shares, increasing direct ownership by 338% to 70 units (SEC Form 4)
Latest TMO
- President & COO Pettiti Gianluca sold $2,898,969 worth of shares (4,133 units at $701.42) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 2% to 22,816 units (SEC Form 4)
- Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026
- Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
- Thermo Fisher Scientific Announces Quarterly Dividend
- SEC Form SCHEDULE 13G filed by Thermo Fisher Scientific Inc
- Director Sperling Scott M gifted 3,490 shares, decreasing direct ownership by 5% to 65,989 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $1,999,960 worth of shares (2,831 units at $706.45) (SEC Form 4)
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by Thermo Fisher Scientific Inc
- SEC Form 8-K filed by Thermo Fisher Scientific Inc